A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
NCT02314689
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Intravenous (IV) citrulline
Sponsor
Suvankar Majumdar